Combimist L Inhaler 200 MD 70 mcg Zydus Healthcare Ltd.

£75.00

Combimist L Inhaler 200 MD 70 mcg is a pharmaceutical bronchodilator preparation manufactured by Zydus Healthcare for laboratory research investigations into respiratory pharmacology and airway smooth muscle modulation studies.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Combimist L Inhaler 200 MD 70 mcg Zydus Healthcare Ltd.
Combimist L Inhaler 200 MD 70 mcg Zydus Healthcare Ltd.
£75.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

About Combimist L Inhaler 200 MD

Combimist L Inhaler 200 MD 70 mcg is a pharmaceutical bronchodilator preparation developed by Zydus Healthcare for comprehensive laboratory research applications. This metered-dose inhaler formulation represents an advanced research tool for investigating respiratory pharmacology, airway smooth muscle modulation, and pulmonary drug delivery mechanisms. Researchers at Stroid UK Shop can examine this preparation’s bronchodilatory properties alongside other research compounds for comparative studies in respiratory physiology and pharmacological intervention models.

Laboratory Applications

This inhaler preparation enables extensive research into bronchodilation mechanisms, airway resistance modulation, and respiratory smooth muscle pharmacology. Investigators can analyse the compound’s interaction with adrenergic receptors and evaluate dose-response relationships in controlled laboratory environments. The metered-dose delivery system facilitates precise dosing studies for research into pulmonary drug delivery optimization. Researchers studying respiratory conditions can examine this preparation alongside compounds from our pharmaceutical research category for comprehensive respiratory pharmacology investigations. The formulation’s stability characteristics make it suitable for extended research protocols examining bronchodilator efficacy and duration of action in experimental models.

Product Specifications

Combimist L Inhaler Research Specifications
Parameter Value
Manufacturer Zydus Healthcare Ltd.
Formulation Metered-dose inhaler
Dose per actuation 70 mcg
Total doses 200 MD
Research grade Pharmaceutical standard
Storage Room temperature, upright

Research teams can complement their respiratory studies by examining this preparation alongside selective compounds from our research modulators and peptide research collections for comprehensive pharmacological investigations.

Research Compliance

Combimist L Inhaler 200 MD 70 mcg is supplied strictly for in-vitro laboratory research purposes only. This preparation is not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must ensure proper laboratory protocols, appropriate storage conditions, and compliance with institutional research guidelines when handling this pharmaceutical preparation.

Related